| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 12/06/2007 | WO2007139099A1 Novel oxidized ldl complex and method for detection thereof |
| 12/06/2007 | WO2007139018A1 Composition for separation of serum or plasma and container for blood test |
| 12/06/2007 | WO2007138964A1 Latex composition for immunoassay |
| 12/06/2007 | WO2007138851A1 III-V SEMICONDUCTOR/SiO2 NANOPARTICLE AND AGENT FOR LABELING BIOLOGICAL SUBSTANCE |
| 12/06/2007 | WO2007138810A1 Prophylactic/therapeutic agent for neurodegenerative disease |
| 12/06/2007 | WO2007138789A1 Immunoassay method and chip |
| 12/06/2007 | WO2007138574A2 Monitoring responsiveness to and screening for therapeutic compounds that modulat composition and structure of cell membranes |
| 12/06/2007 | WO2007138508A1 Sensor device with adaptive field compensation |
| 12/06/2007 | WO2007138402A1 Apparatus and method for fluid density determination |
| 12/06/2007 | WO2007138357A1 Diagnostic assay for spongiform encephalopathies |
| 12/06/2007 | WO2007138163A2 Antibodies and standard for nt-probnp and probnp immunoassays |
| 12/06/2007 | WO2007138098A2 Animal models of tumour metastasis and toxicity |
| 12/06/2007 | WO2007138066A2 Method of screening for compounds that alter skin and/or hair pigmentation |
| 12/06/2007 | WO2007137867A1 Methods for the identification of zap-70 interacting molecules and for the purification of zap-70 |
| 12/06/2007 | WO2007137865A1 The use of mrp 8/14 levels for discrimination of individuals at risk of acute coronary syndromes |
| 12/06/2007 | WO2007137749A1 Method for detecting antibodies and/or antigens and determining the blood type in a test substance |
| 12/06/2007 | WO2007137722A1 Microtiter plate and use thereof |
| 12/06/2007 | WO2007137589A1 Determination of action currents in excitable cells |
| 12/06/2007 | WO2007137584A1 Methods and devices for rapid assessment of severity of injury |
| 12/06/2007 | WO2007137582A1 Methods and devices for rapid assessment of severity of injury and disease |
| 12/06/2007 | WO2007137418A1 Polymer backbone element tags |
| 12/06/2007 | WO2007137414A1 Overexpression of integrin linked kinase (ilk) to improve post-infarct remodeling |
| 12/06/2007 | WO2007137412A1 Nanoporous material |
| 12/06/2007 | WO2007137410A1 Biomarkers for diagnosing multiple sclerosis, and methods thereof |
| 12/06/2007 | WO2007137405A1 Methods of diagnosing and treating rheumatoid arthritis and osteoarthritis |
| 12/06/2007 | WO2007137404A1 Dielectric mapping device and method |
| 12/06/2007 | WO2007124361A3 Soluble b7-h1 |
| 12/06/2007 | WO2007120170A9 Compositions and methods for treating gram positive bacterial infection in a mammalian subject |
| 12/06/2007 | WO2007117439A3 Biomarkers and methods for determining sensitivity to microtubule-stabilizing agents |
| 12/06/2007 | WO2007113590A3 Fluorescent assay |
| 12/06/2007 | WO2007112355A3 Hemoglobin-based methods for prophylaxis, diagnosis and/or treatment of retinal disorders |
| 12/06/2007 | WO2007110756A3 Assay device and method with magnetic field and time-varying signals |
| 12/06/2007 | WO2007110230A3 Secreted proteins as early markers and drug targets for autoimmunity, tumorigenesis and infections |
| 12/06/2007 | WO2007109833B1 Sampling and monitoring of particulate suspension material |
| 12/06/2007 | WO2007109102A3 Methods for interventions and testing for caloric restriction (cr) mimetics |
| 12/06/2007 | WO2007103969A3 Fluidic system for a flow cytometer |
| 12/06/2007 | WO2007103734A3 Method for quantifying an analyte in a biological sample using mass spectrometry |
| 12/06/2007 | WO2007103538A3 Methods of multiple antibody labeling and uses thereof |
| 12/06/2007 | WO2007094983A3 Methods and compositions for the inhibition of hiv infection of t cells |
| 12/06/2007 | WO2007090126A3 Compositions and methods for detecting and quantifying toxic substances in disease states |
| 12/06/2007 | WO2007081982A3 Methods and compositions for mediation of immune responses and adjuvant activity |
| 12/06/2007 | WO2007075910A3 Methods and compositions for detecting enzymatic activity |
| 12/06/2007 | WO2007064964A3 Methods of diagnosing inflammatory bowel disease |
| 12/06/2007 | WO2007056355A3 Devices and methods for culturing, preserving, transporting, storing, reconstituting and assaying cellular materials |
| 12/06/2007 | WO2007056011A3 Methods for prediction and prognosis of cancer, and monitoring cancer therapy |
| 12/06/2007 | WO2007047815A3 Diagnosis of transmissible spongiform encephalopathy |
| 12/06/2007 | WO2007047357A3 Stimulus indicating device employing polymer gels |
| 12/06/2007 | WO2007045903A3 Methods of analysing cell behaviour |
| 12/06/2007 | WO2007044648A3 Oncohumouse |
| 12/06/2007 | WO2007030325A3 Method of hemoglobin correction due to temperature variation |
| 12/06/2007 | WO2007027742A3 SMALL MOLECULE INTEGRIN α2βl/GPIa-IIa ANTAGONISTS |
| 12/06/2007 | WO2007025187A3 Compounds and methods for modulating the silencing of a polynucleotide of interest |
| 12/06/2007 | WO2007000669A3 Use of conjugates with linkers cleavable by photodissociation or fragmentation for mass spectrometry analysis of tissue sections |
| 12/06/2007 | WO2006130689A3 Detecting prostate cancer |
| 12/06/2007 | WO2006130620A3 Modulation of t cell recruitment |
| 12/06/2007 | WO2006122222A3 Shape tunable plasmonic nanoparticles |
| 12/06/2007 | WO2006107684A3 Method and apparatus for automatic cell and biological sample preparation and detection |
| 12/06/2007 | WO2006099624A3 Chemical interaction with metabolites in organism |
| 12/06/2007 | WO2006083853A3 Methods of identification of biomarkers with mass spectrometry techniques |
| 12/06/2007 | WO2006076703A3 Porous biosensing device |
| 12/06/2007 | WO2006066216A3 Rapid microbial detection and antimicrobial susceptibility testing |
| 12/06/2007 | WO2006009843A3 Negative regulation of hypoxia inducible factor 1 by os-9 |
| 12/06/2007 | WO2005081943A3 Molecular flux rates through critical pathways measured by stable isotope labeling in vivo, as biomarkers of drug action and disease activity |
| 12/06/2007 | WO2005080436A3 Antibodies that bind pote and uses thereof |
| 12/06/2007 | WO2005047176A3 Method and system for processing nanoparticles using a self assembly mechanism to form combined species |
| 12/06/2007 | WO2005023199A3 Socs-3 promoter methylation in cancer |
| 12/06/2007 | WO2005022118A3 Methods for optimizing clinical responsiveness to methotrexate therapy using metabolite profiling and pharmacogenetics |
| 12/06/2007 | WO2005017493A3 Biomarkers in cancer |
| 12/06/2007 | WO2004103155A3 Surface-enhanced laser desorption/ionization-based disease diagnosis |
| 12/06/2007 | WO2004085669A3 Identification and quantification of microbial species in a sample |
| 12/06/2007 | WO2004064109A3 Water soluble metal and semiconductor nanoparticle complexes |
| 12/06/2007 | WO2004061417A3 Device structure for closely spaced electrodes |
| 12/06/2007 | WO2004060304A3 Novel compositions and methods in cancer |
| 12/06/2007 | WO2003023001A3 Novel proteins and nucleic acids encoding same |
| 12/06/2007 | US20070283452 Injecting potential tumor cells into a transgenic mouse with a nucleic acid genome encoding the extracellular domain of humanized CTLA4 receptor; administering a candidate drug to the mouse; and monitoring tumor growth |
| 12/06/2007 | US20070283451 Transgenic animals, inhibitors of PKC iota signaling, methods for inhibiting PKC iota signaling, identifying inhibitors of PKC iota signaling, and methods for diagnosing cancer |
| 12/06/2007 | US20070282537 Rapid characterization of post-translationally modified proteins from tandem mass spectra |
| 12/06/2007 | US20070282536 Method and apparatus for evaluating interaction between protein complexes, and computer product |
| 12/06/2007 | US20070282017 Methods and compositions for treating and preventing neurologic disorders |
| 12/06/2007 | US20070282015 Novel Splice Variants of Human Dkkl1 |
| 12/06/2007 | US20070282012 Reagent for Lacrimation Examination and Method of Lacrimation Examination |
| 12/06/2007 | US20070281986 Methods and Compositions for Modulating Satiety |
| 12/06/2007 | US20070281967 Nuclear Transfer Promoter For Rac Protein And Method Of Screening The Dame |
| 12/06/2007 | US20070281896 Novel compositions and methods in cancer |
| 12/06/2007 | US20070281371 Method and apparatus for detection of analyte using a flexural plate wave device and magnetic particles |
| 12/06/2007 | US20070281370 Apparatus for detecting human chorionic gonadotrophin in urine; pregnancy test |
| 12/06/2007 | US20070281369 Acousto-Mechanical Detection Systems and Methods of Use |
| 12/06/2007 | US20070281368 Binding proteins as biosensors |
| 12/06/2007 | US20070281367 Methods, Compositions, and Kits for Quantitating Antibodies |
| 12/06/2007 | US20070281366 Target molecule recognition polymer and method for producing the same |
| 12/06/2007 | US20070281365 Crystal Structure of Erbb2 and Uses Thereof |
| 12/06/2007 | US20070281362 Detection of No With a Semi-Conducting Compound and a Sensor and Device to Detect No |
| 12/06/2007 | US20070281360 Protein detection and quantitation using hydroxyquinolone dyes |
| 12/06/2007 | US20070281359 Method for preparation of microarrays for screening of crystal growth conditions |
| 12/06/2007 | US20070281358 Simultant Material and Method for Manufacture Thereof |
| 12/06/2007 | US20070281357 Fluidic methods for devices for parallel chemical reactions |
| 12/06/2007 | US20070281330 Method for Examining the Activity of Ion Channels |
| 12/06/2007 | US20070281329 Characterization of individual polymer molecules based on monomer-interface interactions |
| 12/06/2007 | US20070281328 identifying a test agent as reducing apoptosis of a macrophage cell; reducing the activity of Protein Kinase R |
| 12/06/2007 | US20070281327 Methods of Screening for Modified Antibodies With Agonistic Activities |